Pulsenmore Ltd 's Quick Ratio

PLSM's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth

In the wake of the increase in Current Liabilities in the fourth quarter 2025, Quick Ratio fell to 1.75 below Pulsenmore Ltd average.

Within Medical Equipment & Supplies industry 68 other companies have achieved higher Quick Ratio than Pulsenmore Ltd in fourth quarter 2025. While Quick Ratio total ranking in the fourth quarter 2025 has deteriorated compared to the prior quarter from to 997.

Explain Quick Ratio?
How much Cash & cash equivalents PLSM�s has?
What are PLSM�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

PLSM Quick Ratio	(Dec 31 2025) Q4	0 Q3	0 Q2	0 Q1	(Dec 31 2024)
Y / Y Current Liabilities Change	-1.12 %	-	-	-	-
Y / Y Cash & cash equivalent Change	-39.9 %	-	-	-	-
Quick Ratio MRQ	1.75	2.09	2.09	2.09	2.89
PLSM's Total Ranking	# 997	#	#	#	#
Seq. Current Liabilities Change	19.17 %	0 %	0 %	-17.03 %	-
Seq. Cash & cash equivalent Change	0 %	0 %	0 %	-39.9 %	-

Quick Ratio fourth quarter 2025 Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 69
Healthcare Sector	# 442
Overall Market	# 997

Quick Ratio Statistics
High	Average	Low
2.09	2.09	2.09
(Dec 31 2025)

Financial Statements
Pulsenmore Ltd 's Current Liabilities	$ 4 Millions	Visit PLSM's Balance sheet
Pulsenmore Ltd 's Cash & cash equivalent	$ 7 Millions	Visit PLSM's Balance sheet
Source of PLSM's Sales		Visit PLSM's Sales by Geography

Cumulative Pulsenmore Ltd 's Quick Ratio

PLSM's Quick Ratio for the trailling 12 Months

PLSM Quick Ratio	(Dec 31 2025) 12 Months	0 12 Months	0 12 Months	0 12 Months	(Dec 31 2024) 12 Months
Y / Y Current Liabilities TTM Growth	247.79 %	-	-	-	-
Y / Y Cash & cash equivalent TTM Growth	140.39 %	-	-	-	-
Quick Ratio TTM	2	2.32	2.39	2.53	2.89
Total Ranking TTM	#	#	#	#	#
Seq. Current Liabilities TTM Growth	-0.32 %	31.2 %	45.35 %	82.97 %	-
Seq. Cash & cash equivalent TTM Growth	-14.24 %	27.29 %	37.54 %	60.1 %	-

Quick ratio ranking by company, industry and sector >> Back to PLSM Financial Strength Comparisons >> Go to Compare PLSM Quick Ratio to its Competitors

On the trailing twelve months basis In spite of the year on year decrease in PLSM's Current Liabilities to $3.86 millions, cumulative Quick Ratio to 2 below the PLSM average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 68 other companies have achieved higher Quick Ratio than Pulsenmore Ltd . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the third quarter 2025 from to 0.

Explain Quick Ratio?
How much Cash & cash equivalents PLSM�s has?
What are PLSM�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Medical Equipment & Supplies Industry	# 69
Healthcare Sector	# 442
Within the Market	# 997

trailing twelve months Quick Ratio Statistics
High	Average	Low
2.09	2.09	2.09
(Dec 31 2025)

Companies with similar Quick Ratio in the quarter ending Dec 31 2025, within Medical Equipment & Supplies Industry	Quick Ratio	Dec 31 2025 MRQ Cash & cash equivalent	Dec 31 2025 MRQ Current Liabilities
Sensus Healthcare Inc	4.68	$ 22.083 Millions	$ 4.722 Millions
Orasure Technologies Inc	4.64	$ 199.278 Millions	$ 42.947 Millions
Outset Medical Inc	4.49	$ 168.946 Millions	$ 37.630 Millions
Irhythm Holdings Inc	4.46	$ 583.763 Millions	$ 131.003 Millions
Omada Health Inc	4.38	$ 222.036 Millions	$ 50.668 Millions
Procept Biorobotics Corporation	4.35	$ 286.503 Millions	$ 65.795 Millions
Clearpoint Neuro Inc	4.27	$ 45.923 Millions	$ 10.765 Millions
Nexalin Technology Inc	4.20	$ 3.723 Millions	$ 0.887 Millions
Alpha Pro Tech Ltd	4.19	$ 16.988 Millions	$ 4.058 Millions
Vicarious Surgical Inc	3.96	$ 9.792 Millions	$ 2.475 Millions
Icecure Medical Ltd	3.90	$ 8.897 Millions	$ 2.280 Millions
Regentis Biomaterials Ltd	3.89	$ 7.378 Millions	$ 1.895 Millions
Biolife Solutions Inc	3.87	$ 88.927 Millions	$ 22.979 Millions
Solana Company	3.85	$ 7.282 Millions	$ 1.890 Millions
Anika Therapeutics Inc	3.71	$ 81.171 Millions	$ 21.908 Millions
Novocure Limited	3.66	$ 447.674 Millions	$ 122.231 Millions
Pulmonx Corporation	3.48	$ 69.751 Millions	$ 20.058 Millions
Inspira Technologies Oxy B H N Ltd	3.44	$ 6.416 Millions	$ 1.864 Millions
Neuropace Inc	3.43	$ 61.058 Millions	$ 17.814 Millions
Co diagnostics Inc	3.36	$ 11.885 Millions	$ 3.540 Millions
Mobia Medical Inc	3.29	$ 33.587 Millions	$ 10.206 Millions
Strata Critical Medical Inc	3.21	$ 61.495 Millions	$ 19.142 Millions
Inspire Medical Systems inc	3.21	$ 308.268 Millions	$ 96.055 Millions
Seastar Medical Holding Corp	3.20	$ 11.980 Millions	$ 3.742 Millions
Brainsway Ltd	3.01	$ 67.700 Millions	$ 22.495 Millions
Femasys Inc	2.99	$ 9.266 Millions	$ 3.096 Millions
Hyperfine Inc	2.99	$ 35.085 Millions	$ 11.732 Millions
Penumbra Inc	2.97	$ 544.816 Millions	$ 183.133 Millions
Intuitive Surgical Inc	2.96	$ 5,934.900 Millions	$ 2,006.200 Millions
Aethlon Medical Inc	2.90	$ 5.501 Millions	$ 1.899 Millions

Date modified: 2026-09-08T15:11:39+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.